Skip to content
10-Q

Quarterly Report

DOLBY LABORATORIES, INC. DLB

0001628280-25-003175

← back to feed
Filed
Jan 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents Q1 2025 · Dec 27, 2024 $520.82M
Cash And Equivalents Q1 2025 · Sep 27, 2024 $482.05M
Stockholders Equity Q1 2025 · Dec 27, 2024 $2.51B
Stockholders Equity Q1 2025 · Sep 27, 2024 $2.48B
Current Liabilities Q1 2025 · Dec 27, 2024 $441.88M
Current Liabilities Q1 2025 · Sep 27, 2024 $417.84M
Total Liabilities Q1 2025 · Dec 27, 2024 $641.57M
Total Liabilities Q1 2025 · Sep 27, 2024 $623.04M
Current Assets Q1 2025 · Dec 27, 2024 $1.29B
Current Assets Q1 2025 · Sep 27, 2024 $1.19B
Total Assets Q1 2025 · Dec 27, 2024 $3.16B
Total Assets Q1 2025 · Sep 27, 2024 $3.11B
Shares Diluted Q1 2025 · Dec 29, 2023 97.44M sh
Stock Repurchased Q1 2025 · Dec 29, 2023 $80M
Dividends Paid Q1 2025 · Dec 29, 2023 $28.55M
Capex Q1 2025 · Dec 29, 2023 $6.1M
Operating Cash Flow Q1 2025 · Dec 29, 2023 $8.41M
Eps Diluted Q1 2025 · Dec 29, 2023 $0.69
Eps Basic Q1 2025 · Dec 29, 2023 $0.70
Sga Expense Q1 2025 · Dec 29, 2023 $65.17M
Rd Expense Q1 2025 · Dec 29, 2023 $67.03M
Net Income Q1 2025 · Dec 29, 2023 $66.98M
Operating Income Q1 2025 · Dec 29, 2023 $66.22M
Gross Profit Q1 2025 · Dec 29, 2023 $283.51M
Cost Of Revenue Q1 2025 · Dec 29, 2023 $32.06M
Revenue Q1 2025 · Dec 29, 2023 $315.57M